New drug CBP-4888 passes first safety check in healthy volunteers
NCT ID NCT05881993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called CBP-4888 in 45 healthy women who were not pregnant. The goal was to see if the drug is safe and how the body processes it. Participants received either a single dose of the drug or a placebo. The study did not aim to treat any disease, only to gather early safety information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Comanche Biopharma Clinical Research Site #1
San Antonio, Texas, 78217, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New asthma drug candidate enters first human safety tests
- Variety beats repetition: study shows mixing it up improves motor learning
- Pain-Free shots? study tests if preservative is the culprit
- Scientists deliberately infect volunteers with whooping cough to study natural defenses
- Could a nerve channel blocker replace opioids? early study investigates
- New pain pill takes first step: safe in healthy volunteers?